Natasha L Grimsey (Natasha Grimsey)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Topics

Binding Protein

Genome Wide Association

Fluorescent Probe

Top Venues

British journal of pharmacology

Journal of medicinal chemistry

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Nicola J Smith, Lauren T May, Natasha L Grimsey
Highlights and hot topics in GPCR research from 'Down Under'. British journal of pharmacology 181 (14) (2024)
Nicola J Smith, Lauren T May, Natasha L Grimsey
Highlights and hot topics in GPCR research from 'Down Under'. British journal of pharmacology (2024)
Tahira Foyzun, Maddie Whiting, Kate K Velasco, Jessie C Jacobsen, Mark Connor, Natasha L Grimsey
Single nucleotide polymorphisms in the cannabinoid CB 2 receptor: Molecular pharmacology and disease associations. British journal of pharmacology 181 (15) (2024)
Tahira Foyzun, Maddie Whiting, Kate K Velasco, Jessie C Jacobsen, Mark Connor, Natasha L Grimsey
Single nucleotide polymorphisms in the cannabinoid CB 2 receptor: Molecular pharmacology and disease associations. British journal of pharmacology 181 (15) (2024)
Tahira Foyzun, Maddie Whiting, Kate K Velasco, Jessie C Jacobsen, Mark Connor, Natasha L Grimsey
Single nucleotide polymorphisms in the cannabinoid CB 2 receptor: Molecular pharmacology and disease associations. British journal of pharmacology (2024)
Nicola J Smith, Lauren T May, Natasha L Grimsey
Highlights and hot topics in GPCR research from 'Down Under'. British journal of pharmacology 181 (14) (2024)
Emma R Carruthers, Natasha L Grimsey
Cannabinoid Receptor 2 (CB2) Orthologue In Vitro Function and Perspectives for Preclinical to Clinical Translation. British journal of pharmacology (2023)
Nathaniel A K Glenn, David B Finlay, Emma R Carruthers, Kathleen G Mountjoy, Christopher S Walker, Natasha L Grimsey
RAMP and MRAP Accessory Proteins have Selective Effects on Expression and Signalling of the CB1, CB2, GPR18 and GPR55 Cannabinoid Receptors. British journal of pharmacology (2023)
Monica Patel, Natasha L Grimsey, Samuel D Banister, David B Finlay, Michelle Glass
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB 2 receptor. Pharmacology research & perspectives 11 (6) (2023)
Nathaniel A K Glenn, David B Finlay, Emma R Carruthers, Kathleen G Mountjoy, Christopher S Walker, Natasha L Grimsey
RAMP and MRAP Accessory Proteins have Selective Effects on Expression and Signalling of the CB1, CB2, GPR18 and GPR55 Cannabinoid Receptors. British journal of pharmacology (2023)
Nathaniel A K Glenn, David B Finlay, Emma R Carruthers, Kathleen G Mountjoy, Christopher S Walker, Natasha L Grimsey
RAMP and MRAP Accessory Proteins have Selective Effects on Expression and Signalling of the CB1, CB2, GPR18 and GPR55 Cannabinoid Receptors. British journal of pharmacology (2023)
Raahul Sharma, Sameek Singh, Zak M Whiting, Maximilian Molitor, Andrea J Vernall, Natasha L Grimsey
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias. International journal of molecular sciences 24 (7) (2023)
Nathaniel A K Glenn, David B Finlay, Emma R Carruthers, Kathleen G Mountjoy, Christopher S Walker, Natasha L Grimsey
RAMP and MRAP Accessory Proteins have Selective Effects on Expression and Signalling of the CB1, CB2, GPR18 and GPR55 Cannabinoid Receptors. British journal of pharmacology (2023)
Karine Mardon, Jayendra Z Patel, Juha R Savinainen, Damion H R Stimson, Caitlin R M Oyagawa, Natasha L Grimsey, Mary-Anne Migotto, Grace F M Njiru, Brett R Hamilton, Gary Cowin, Jari T Yli-Kauhaluoma, Wim Vanduffel, Idriss Blakey, Rajiv Bhalla, Christopher J Cawthorne, Sofie Celen, Guy Bormans, Kristofer J Thurecht, Muneer Ahamed
Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α / β -Hydrolase Domain 6 (ABHD6). Journal of medicinal chemistry 66 (1) (2022)
Karine Mardon, Jayendra Z Patel, Juha R Savinainen, Damion H R Stimson, Caitlin R M Oyagawa, Natasha L Grimsey, Mary-Anne Migotto, Grace F M Njiru, Brett R Hamilton, Gary Cowin, Jari T Yli-Kauhaluoma, Wim Vanduffel, Idriss Blakey, Rajiv Bhalla, Christopher J Cawthorne, Sofie Celen, Guy Bormans, Kristofer J Thurecht, Muneer Ahamed
Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α / β -Hydrolase Domain 6 (ABHD6). Journal of medicinal chemistry 66 (1) (2022)
Karine Mardon, Jayendra Z Patel, Juha R Savinainen, Damion H R Stimson, Caitlin R M Oyagawa, Natasha L Grimsey, Mary-Anne Migotto, Grace F M Njiru, Brett R Hamilton, Gary Cowin, Jari T Yli-Kauhaluoma, Wim Vanduffel, Idriss Blakey, Rajiv Bhalla, Christopher J Cawthorne, Sofie Celen, Guy Bormans, Kristofer J Thurecht, Muneer Ahamed
Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α / β -Hydrolase Domain 6 (ABHD6). Journal of medicinal chemistry 66 (1) (2022)
Karine Mardon, Jayendra Z Patel, Juha R Savinainen, Damion H R Stimson, Caitlin R M Oyagawa, Natasha L Grimsey, Mary-Anne Migotto, Grace F M Njiru, Brett R Hamilton, Gary Cowin, Jari T Yli-Kauhaluoma, Wim Vanduffel, Idriss Blakey, Rajiv Bhalla, Christopher J Cawthorne, Sofie Celen, Guy Bormans, Kristofer J Thurecht, Muneer Ahamed
Utilizing PET and MALDI Imaging for Discovery of a Targeted Probe for Brain Endocannabinoid α / β -Hydrolase Domain 6 (ABHD6). Journal of medicinal chemistry (2022)
Preeti Manandhar, Bridin Patricia Murnion, Natasha L Grimsey, Mark Connor, Marina J Santiago
Do gabapentin or pregabalin directly modulate the µ receptor? PeerJ 9 (2021)
Roman C Sarott, Matthias V Westphal, Patrick Pfaff, Claudia Korn, David A Sykes, Thais Gazzi, Benjamin Brennecke, Kenneth Atz, Marie Weise, Yelena Mostinski, Pattarin Hompluem, Eline Koers, Tamara Miljuš, Nicolas J Roth, Hermon Asmelash, Man C Vong, Jacopo Piovesan, Wolfgang Guba, Arne C Rufer, Eric A Kusznir, Sylwia Huber, Catarina Raposo, Elisabeth A Zirwes, Anja Osterwald, Anto Pavlovic, Svenja Moes, Jennifer Beck, Irene Benito-Cuesta, Teresa Grande, Samuel Ruiz de Martı N Esteban, Alexei Yeliseev, Faye Drawnel, Gabriella Widmer, Daniela Holzer, Tom van der Wel, Harpreet Mandhair, Cheng-Yin Yuan, William R Drobyski, Yurii Saroz, Natasha L Grimsey, Michael Honer, Jürgen Fingerle, Klaus Gawrisch, Julian Romero, Cecilia J Hillard, Zoltan V Varga, Mario van der Stelt, Pal Pacher, Jürg Gertsch, Peter J McCormick, Christoph Ullmer, Sergio Oddi, Mauro Maccarrone, Dmitry B Veprintsev, Marc Nazare, Uwe Grether, Erick M Carreira
Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells. Journal of the American Chemical Society 142 (40) (2020)
Alexander Gillis, Arisbel B Gondin, Andrea Kliewer, Julie Sanchez, Herman D Lim, Claudia Alamein, Preeti Manandhar, Marina J Santiago, Sebastian Fritzwanker, Frank Schmiedel, Timothy A Katte, Tristan A Reekie, Natasha L Grimsey, Michael Kassiou, Barrie Kellam, Cornelius Krasel, Michelle L Halls, Mark Connor, J Robert Lane, Stefan Schulz, Macdonald J Christie, Meritxell Canals
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Science signaling 13 (625) (2020)
Anna G Cooper, Caitlin R M Oyagawa, Jamie J Manning, Sameek Singh, Sarah Hook, Natasha L Grimsey, Michelle Glass, Joel D A Tyndall, Andrea J Vernall
Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold. MedChemComm 9 (12) (2018)
David B Finlay, Erin E Cawston, Natasha L Grimsey, Morag Rose Hunter, Anisha Korde, V Kiran Vemuri, Alexandros Makriyannis, Michelle Glass
Gαs signalling of the CB1 receptor and the influence of receptor number. British journal of pharmacology 174 (15) (2017)